Glucagon-like peptide-1 agonists (GLP-1) are a class of medications that can be extremely effective at reducing blood sugar and A1C levels for those with type 2 diabetes
Patients with chronic diabetes are more likely to suffer cognitive impairment, and a number of neurodegenerative disorders, including Alzheimers Disease (AD), Parkinsons Disease and other forms of dementia
Therefore, prioritizing both a balanced diet and a healthy lifestyle can be crucial for optimizing GLP-1 function and supporting metabolic health
Whereas GH deficiency according to the negative effects of elevated GH levels on glucose homeostasis would be expected to result in beneficial effects the findings of available studies on this topic are inconsistent
These medications act as a GLP-1 receptor agonist, mimicking the bodys natural GLP-1 hormone
Of 1,956 participants (STEP 1, n = 1,311